{{Rsnum
|rsid=1994816
|Chromosome=4
|position=180047278
|Orientation=plus
|GMAF=0.2782
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 20.4 | 77.9
| HCB | 8.8 | 46.0 | 45.3
| JPT | 5.3 | 34.5 | 60.2
| YRI | 26.2 | 49.6 | 24.1
| ASW | 17.5 | 54.4 | 28.1
| CHB | 8.8 | 46.0 | 45.3
| CHD | 12.8 | 48.6 | 38.5
| GIH | 18.8 | 42.6 | 38.6
| LWK | 13.0 | 54.6 | 32.4
| MEX | 10.3 | 41.4 | 48.3
| MKK | 17.1 | 40.8 | 42.1
| TSI | 2.9 | 24.5 | 72.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23502783
  |Trait=Multiple myeloma (IgH translocation)
  |Title=The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
  |RiskAllele=A
  |Pval=5E-7
  |OR=1.76
  |ORtxt=[1.41-2.20]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}